This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


18Jan 2019

Back to Seminars overview

International seminar by Ze’ev Ronai

Ze'ev Ronai
Sanford Burnham Prebys Medical Discovery Institute, La Jolla,USA

Coordinated Regulation of Gut Microbiome and Anti-Tumor Immunity by The Ubiquitin Ligase RNF5

Friday, January 18, 2019, 11.00 hrs
Piet Borst Auditorium

Host     : Daniel Peeper
E-mail  :

Ze'ev Ronai
Obtained his PhD in Tumor Immunology from the Hebrew University in Jerusalem, Israel, followed by postdoctoral training at Columbia University in New York. He was tenured professor at the Ruttenberg Cancer Center at Mount SinaiSchool of Medicine in New York before joining Sanford Burnham Prebys Medical Discovery Institute in Ja Jolla, CA where he has served as Program Director, Deputy Director to the Cancer Center, and as the Scientific Director.  Over the past five years Dr. Ronai co-led the establishment of integrated cancer center at the Technion, Israel. Dr Ronai study the role of ubiquitin ligases in the regulation of hypoxia and ER stress and the implications of such regulation on cancer development, progression and resistance. Ongoing studies extend intrinsic cellular pathways that are regulated by ubiquitin ligases to their role in tumor microenvironment, with focus on the anti-tumor immunity in melanoma.   

Share this page